Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Inspyr Therapeutics, Inc. | v434243_ex32-1.htm |
| 10-K - 10-K - Inspyr Therapeutics, Inc. | v434243_10k.htm |
| EX-31.2 - EXHIBIT 31.2 - Inspyr Therapeutics, Inc. | v434243_ex31-2.htm |
| EX-32.2 - EXHIBIT 32.2 - Inspyr Therapeutics, Inc. | v434243_ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Inspyr Therapeutics, Inc. | v434243_ex31-1.htm |
Exhibit 23.01
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (SEC File No. 333-192553) of GenSpera, Inc. of our report which includes an explanatory paragraph as to the Company’s ability to continue as a going concern dated March 30, 2016 relating to our audit of the financial statements which appear in this Annual Report on Form 10-K of GenSpera, Inc. for the years ended December 31, 2015 and 2014.
/s/ Liggett & Webb, P.A.
March 30, 2016
New York, New York